Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions - PubMed

Review

Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions

S J Shiff et al. Gastroenterology. 1997 Dec.

Similar articles

• Polyamine metabolism and cancer prevention.

  Saunders FR, Wallace HM. Saunders FR, et al. Biochem Soc Trans. 2007 Apr;35(Pt 2):364-8. doi: 10.1042/BST0350364. Biochem Soc Trans. 2007. PMID: 17371279

• Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.

  Huls G, Koornstra JJ, Kleibeuker JH. Huls G, et al. Lancet. 2003 Jul 19;362(9379):230-2. doi: 10.1016/s0140-6736(03)13915-3. Lancet. 2003. PMID: 12885487 Review.

• Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.

  Jalving M, Koornstra JJ, De Jong S, De Vries EG, Kleibeuker JH. Jalving M, et al. Aliment Pharmacol Ther. 2005 Feb 15;21(4):321-39. doi: 10.1111/j.1365-2036.2005.02335.x. Aliment Pharmacol Ther. 2005. PMID: 15709983 Review.

• The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention.

  Bertagnolli MM. Bertagnolli MM. J Surg Oncol. 2003 Nov;84(3):113-9. doi: 10.1002/jso.10279. J Surg Oncol. 2003. PMID: 14598353 Review. No abstract available.

• Non-steroidal anti-inflammatory drugs in the treatment of colorectal cancer.

  Morgan G. Morgan G. Eur J Cancer. 1997 Jul;33(8):1335-6. doi: 10.1016/s0959-8049(97)00046-4. Eur J Cancer. 1997. PMID: 9301466 No abstract available.

Cited by

• Cyclooxygenase-2 inhibitor nimesulide suppresses telomerase activity by blocking Akt/PKB activation in gastric cancer cell line.

  Baoping Y, Guoyong H, Jieping Y, Zongxue R, Hesheng L. Baoping Y, et al. Dig Dis Sci. 2004 Jun;49(6):948-53. doi: 10.1023/b:ddas.0000034553.58554.ab. Dig Dis Sci. 2004. PMID: 15309882

• Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells.

  Castaño E, Dalmau M, Barragán M, Pueyo G, Bartrons R, Gil J. Castaño E, et al. Br J Cancer. 1999 Sep;81(2):294-9. doi: 10.1038/sj.bjc.6690690. Br J Cancer. 1999. PMID: 10496355 Free PMC article.

• Cyclooxygenase-2 and its role in colorectal cancer development.

  Wendum D, Masliah J, Trugnan G, Fléjou JF. Wendum D, et al. Virchows Arch. 2004 Oct;445(4):327-33. doi: 10.1007/s00428-004-1105-2. Epub 2004 Sep 1. Virchows Arch. 2004. PMID: 15340847 Review.

• Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors.

  Harris RE, Beebe J, Alshafie GA. Harris RE, et al. J Exp Pharmacol. 2012 Aug 10;4:91-6. doi: 10.2147/JEP.S23826. eCollection 2012. J Exp Pharmacol. 2012. PMID: 27186121 Free PMC article. Review.

• The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs).

  Shiff SJ, Rigas B. Shiff SJ, et al. J Exp Med. 1999 Aug 16;190(4):445-50. doi: 10.1084/jem.190.4.445. J Exp Med. 1999. PMID: 10449515 Free PMC article. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information